Product
DHA-PIP
1 clinical trial
1 indication
Indication
MalariaClinical trial
A Randomized, Open Label, Single Centre, Phase 2 Trial of the Malaria Vaccine, R21/Matrix-M, to Assess Safety and Immunogenicity of the Vaccine in Thai AdultsStatus: Completed, Estimated PCD: 2023-06-08